GENEVA, Dec. 10 -- HANMI PHARM. CO. LTD. (214 Muha-ro, Paltan-myeon, Hwaseong-siGyeonggi-doGyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/007240) for "NOVEL SULFAMIDE CAMPTOTHECIN DERIVATIVES WITH ANTITUMOR ACTIVITY" on May 28, 2025. With publication no. WO/2025/249897, the details related to the patent application was published on Dec 04, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KIM, Jae Woong (214 Muha-r...